# | ||||
---|---|---|---|---|
1 | BIOSIM Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence | 2017 | 2˙029˙325.00 | 2˙029˙325.00 |
2 | ILCA Intelligent Live Cell Analysis [iLCA] to transform disease management through faster, and more regulatory robust, discovery, manufacture and monitoring of biologic drugs & cell therapies | 2019 | 3˙483˙633.00 | 2˙438˙543.00 |
3 | II-LCA Integrated Imaging in live Cell Analysis (II-LCA), for enhanced development and manufacturing of biologic and cell therapies. | 2019 | 123˙746.00 | 123˙746.00 |
The Institution VALITACELL LTD has been involved also in the following Horizon 2020 projects.